210 related articles for article (PubMed ID: 33620517)
1. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
[TBL] [Abstract][Full Text] [Related]
2. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
3. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
4. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
6. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
8. Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes.
Shi S; Yu L; Zhang T; Qi H; Xavier S; Ju W; Bottinger E
PLoS One; 2013; 8(9):e75572. PubMed ID: 24086574
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
11. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
Huang F; Sheng XX; Zhang HJ
Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
[TBL] [Abstract][Full Text] [Related]
12. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
13. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
14. EGF receptor deletion in podocytes attenuates diabetic nephropathy.
Chen J; Chen JK; Harris RC
J Am Soc Nephrol; 2015 May; 26(5):1115-25. PubMed ID: 25185988
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
16. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
[TBL] [Abstract][Full Text] [Related]
17. Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi.
Sugioka S; Yamada H; Ishii A; Kato Y; Yamada R; Mori KP; Ohno S; Handa T; Ikushima A; Ishimura T; Osaki K; Tokudome T; Matsusaka T; Nebreda AR; Yanagita M; Yokoi H
Kidney Int; 2023 Sep; 104(3):508-525. PubMed ID: 37356621
[TBL] [Abstract][Full Text] [Related]
18. Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
Ma X; Schwarz A; Sevilla SZ; Levin A; Hultenby K; Wernerson A; Lal M; Patrakka J
J Am Soc Nephrol; 2018 Jun; 29(6):1679-1689. PubMed ID: 29636387
[No Abstract] [Full Text] [Related]
19. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK.
Yoshida S; Nagase M; Shibata S; Fujita T
Nephron Exp Nephrol; 2008; 108(3):e57-68. PubMed ID: 18391505
[TBL] [Abstract][Full Text] [Related]
20. Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo.
Gui D; Wei L; Jian G; Guo Y; Yang J; Wang N
Cell Physiol Biochem; 2014; 34(6):1849-62. PubMed ID: 25503068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
